561 Nonclinical characterization of the first in class...

European Journal of Cancer 2014 / 11 Vol. 50

561 Nonclinical characterization of the first in class investigational ubiquitin activating enzyme inhibitor MLN7243 in cellular and in vivo models of cancer in support of a phase I study

Milhollen, M., Hyer, M., Ciavarri, J., Traore, T., Sappal, D., Huck, J., Shi, J., Duffy, J., Gavin, J., Brownell, J., Yang, Y., Stringer, B., Ishii, Y., Koenig, E., Lublinsky, A., Griffin, R., Xia, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70687-2
Date:
November, 2014
File:
PDF, 74 KB
english, 2014
Conversion to is in progress
Conversion to is failed